Elliot P Cowan
Biographic Data
| ID | 7017688 |
|---|---|
| NAME | Elliot P Cowan |
| GIVEN NAMES | Elliot P |
| FAMILY NAME | Cowan |
| SIGNATURE | COWAN E P |
| AFFILIATIONS | Medical Discovery Partners (United States) |
| ORCID | 0000-0001-5138-4209 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2014 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Improving the efficiency of the regulatory approvals of HIV in vitro diagnostics in low- and middle-income countries
In vitro diagnostics (IVDs) play a pivotal role in healthcare for the prevention, diagnosis, and treatment of infectious diseases, especially during epidemic and pandemic outbreaks. Improving access to IVDs holds promise for better healthcare outcomes, particularly in resource-limited settings. However, challenges persist, such as regulatory disparities and financial constraints, hindering broad access to IVDs. To address these challenges, the In…
HIV Self-Testing in Resource-Limited Settings
HIV self-testing (HIVST) is an emerging HIV testing strategy intended to address challenges of increasing access to preliminary knowledge of serostatus. It offers the potential for tests and testing to reach more people than previously possible, including those who do not seek testing in facilities. With approval of an HIV self-test kit in the USA, increasing evidence from public pilot programs in sub-Saharan Africa showing high acceptability and…
No prominent works on this page.
HIV Self-Testing in Resource-Limited Settings
HIV self-testing (HIVST) is an emerging HIV testing strategy intended to address challenges of increasing access to preliminary knowledge of serostatus. It offers the potential for tests and testing to reach more people than previously possible, including those who do not seek testing in facilities. With approval of an HIV self-test kit in the USA, increasing evidence from public pilot programs in sub-Saharan Africa showing high acceptability and…
Improving the efficiency of the regulatory approvals of HIV in vitro diagnostics in low- and middle-income countries
In vitro diagnostics (IVDs) play a pivotal role in healthcare for the prevention, diagnosis, and treatment of infectious diseases, especially during epidemic and pandemic outbreaks. Improving access to IVDs holds promise for better healthcare outcomes, particularly in resource-limited settings. However, challenges persist, such as regulatory disparities and financial constraints, hindering broad access to IVDs. To address these challenges, the In…
Business (2 works) · Economic growth (2 works) · Economics (2 works) · HIV/AIDS Research and Interventions (2 works) · Medicine (2 works) · Political science (2 works) · Public relations (2 works) · Best practice (1 work) · Computer Science (1 work) · Environmental health (1 work)